These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11779302)

  • 1. Expression of telomerase activity in cholesteatoma otitis media.
    Goh EK; Lee BJ; Wang SG; Chon KM; Kim CM
    J Laryngol Otol; 2001 Nov; 115(11):881-4. PubMed ID: 11779302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity and cell proliferation index in cholesteatoma.
    Lee SH; Jang YH; Tae K; Park YW; Kang MJ; Kim KR; Park CW
    Acta Otolaryngol; 2005 Jul; 125(7):707-12. PubMed ID: 16012031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
    Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
    Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity, telomere length, and apoptosis: a comparison between acquired cholesteatoma and squamous cell carcinoma.
    Watabe-Rudolph M; Rudolph KL; Averbeck T; Buhr T; Lenarz T; Stöver T
    Otol Neurotol; 2002 Sep; 23(5):793-8. PubMed ID: 12218637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length.
    Kojima H; Miyazaki H; Shiwa M; Tanaka Y; Moriyama H
    Laryngoscope; 2001 May; 111(5):867-73. PubMed ID: 11359168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R; Welkoborsky HJ; Mann W
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and significance of TERT and c-Myc oncogene protein product on cholesteatoma epithelium].
    Zhang F; Liu J; Yuan T; Liu Q; Han Z; Wang S; Zhang C; Chen S
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):302-4. PubMed ID: 16001896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The localization of matrix metalloproteinases-8 and -13 in cholesteatoma, deep-meatal and post-auricular skin: a comparative analysis.
    Mehta D; Daudia A; Birchall JP; Banerjee AR
    Acta Otolaryngol; 2007 Feb; 127(2):138-42. PubMed ID: 17364344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
    Wang H; Xu Z; Tang A; Su J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):620-2. PubMed ID: 15620146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of caspase-14 in human middle ear cholesteatoma.
    Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
    Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased permeability of the epithelium of middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ohbuchi T; Kitamura T; Hashida K; Nakamura M
    Clin Otolaryngol; 2015 Apr; 40(2):106-14. PubMed ID: 25319490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.
    Huisman MA; De Heer E; Grote JJ
    Acta Otolaryngol; 2003 Apr; 123(3):377-82. PubMed ID: 12737294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
    Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
    Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study.
    Akdogan V; Yilmaz I; Canpolat T; Ozluoglu LN
    J Laryngol Otol; 2013 Mar; 127(3):252-9. PubMed ID: 23331470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.
    Shieh TJ; Ho KY; Kuo WR; Chai CY; Lin CS; Juan KH
    Kaohsiung J Med Sci; 1999 Aug; 15(8):468-74. PubMed ID: 10518363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential gene expression in cholesteatoma by DNA chip analysis.
    Macias JD; Gerkin RD; Locke D; Macias MP
    Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a relationship between myeloperoxidase activity and conductive hearing loss in chronic otitis media complicated by cholesteatoma?
    Celebi Erdivanli O; Sanli A
    Ear Nose Throat J; 2015; 94(4-5):166-92. PubMed ID: 25923274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of N-acetyl-beta-d-hexosaminidase in cholesteatoma tissue.
    Olszewska E; Olszewski S; Borzym-Kluczyk M; Zwierz K
    Acta Biochim Pol; 2007; 54(2):365-70. PubMed ID: 17502924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.